Crossroads Urology Center is more than a real estate investment—it’s the foundation of a mission to elevate access to high-quality urologic care across Northwest Ohio and the surrounding region.
CC Urology Center Real Estate, LLC was formed to develop and own a purpose-built, fully pre-leased medical facility anchored by West Central Ohio Urological Centers of Excellence, a dedicated ambulatory surgery center, and a national laboratory partner. With an experienced physician leadership team and stable long-term leases in place, the project is designed to deliver both meaningful community impact and consistent investor returns.
At a time when public markets are volatile and traditional real estate sectors are facing headwinds, medical real estate—and particularly specialty-driven centers—have shown resilience and growth. Crossroads Urology Center offers investors a rare opportunity to combine mission-aligned investment with stable cash flow, long-term tenant security, and future equity upside, all in a critical and growing segment of healthcare.
This project is about more than financial returns; it’s about restoring physician leadership in healthcare, expanding access for patients, and building an enduring, profitable asset that improves lives for decades to come.
Strategic Location and Regional Reach
The Center will be located on a 5.75-acre parcel at the intersection of Interstate 75 and National Road in Cridersville, Ohio—a prime, highly visible location between Columbus, Dayton, Toledo, and Fort Wayne, Indiana. This positioning places the Center within a two-hour drive of over 22 million people and addresses a critical shortage of specialized urologic care across the region.
Purpose-Built Medical Facility
The two-story, 43,000-square-foot medical complex is meticulously designed to maximize operational efficiency, patient flow, and long-term tenant functionality, with dedicated spaces including:
Anchored by Long-Term, Committed Tenants
The project is led by Nicholson Urology LLC, which has executed a Letter of Intent (LOI) to lease 41,500 sq ft of the total space, ensuring strong occupancy from day one. Pathology Laboratories, Inc.—a leading national lab partner—has also committed to lease an additional 1,500 sq ft for an onsite pathology lab. These tenancy agreements establish a stable income base and significantly derisk the investment for Class A Members.
$50,000 minimum investment to become a Class A Member; $25,000 per Class A Unit; upon completion of a fully subscribed Offering there will be approximately 320 Class A Units issued and outstanding. Early investors benefit not only from strong cash flow supported by long-term medical leases, but also from the opportunity to participate in a project that combines healthcare innovation, community impact, and resilient real estate ownership.
Maximum Offering | $8,000,000 |
Minimum Investment | $50,000 |
Per Class A Unit | $25,000 |
Total Class A Units (Fully Subscribed) | 320 |
Hard Costs & Capital Reserves (50%)
This includes all direct expenditures related to the building itself—land acquisition, construction, architectural and engineering fees, site development, and a capital reserve fund to support future improvements and long-term stability.
Administrative & Launch Costs (22%)
Covers key upfront costs for legal, accounting, advisory, and administrative setup. This also includes the development fee and closing costs necessary to bring the offering to market and complete all financing.
Working Capital (28%)
Allocated to ensure operational flexibility during the early stages of development. This reserve allows the sponsor to cover any unforeseen costs, support lease-up efforts, and provide cash flow stability as the project matures.